Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.

LAB

Standard BioTools (LAB)

Standard BioTools Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:LAB
일자시간출처헤드라인심볼기업
2024/04/2521:01GlobeNewswire Inc.Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable GrowthNASDAQ:LABStandard BioTools Inc
2024/04/2521:00GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for First Quarter 2024 Financial Results on May 8, 2024NASDAQ:LABStandard BioTools Inc
2024/04/0821:00GlobeNewswire Inc.Standard BioTools Introduces New High-Throughput Multiplexed Whole Slide Imaging Modalities Set to Redefine the boundaries of Tissue ImagingNASDAQ:LABStandard BioTools Inc
2024/04/0405:01GlobeNewswire Inc.Standard BioTools Announces Multi-Year Strategic Engagement with Bristol Myers Squibb for Use of the SomaScan® Platform for Translational Medicine ResearchNASDAQ:LABStandard BioTools Inc
2024/03/1821:12GlobeNewswire Inc.Standard BioTools Announces Exchange of All Outstanding Series B Convertible Preferred Stock for Common StockNASDAQ:LABStandard BioTools Inc
2024/03/0709:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
2024/02/2906:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LABStandard BioTools Inc
2024/02/2906:01GlobeNewswire Inc.Standard BioTools Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:LABStandard BioTools Inc
2024/02/2706:15Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LABStandard BioTools Inc
2024/02/2622:00GlobeNewswire Inc.Standard BioTools and Next Gen Diagnostics Announce Partnership to Provide Complete Automation of Low-Cost Pathogen SequencingNASDAQ:LABStandard BioTools Inc
2024/02/2307:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
2024/02/2306:05GlobeNewswire Inc.Standard BioTools to Participate in Upcoming Investor ConferencesNASDAQ:LABStandard BioTools Inc
2024/02/1505:32Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:LABStandard BioTools Inc
2024/02/1422:30GlobeNewswire Inc.Standard BioTools Announces Conference Call and Webcast for Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024NASDAQ:LABStandard BioTools Inc
2024/02/0814:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LABStandard BioTools Inc
2024/02/0814:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LABStandard BioTools Inc
2024/02/0722:30GlobeNewswire Inc.Standard BioTools and Navignostics Announce Collaboration Agreement to Advance Imaging Capabilities in Personalized MedicineNASDAQ:LABStandard BioTools Inc
2024/02/0306:49Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:LABStandard BioTools Inc
2024/01/2007:07Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LABStandard BioTools Inc
2024/01/2007:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LABStandard BioTools Inc
2024/01/2007:03Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LABStandard BioTools Inc
2024/01/2006:48Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:LABStandard BioTools Inc
2024/01/2006:33Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:LABStandard BioTools Inc
2024/01/1304:04Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:LABStandard BioTools Inc
2024/01/1010:51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
2024/01/1008:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
2024/01/1008:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
2024/01/1008:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
2024/01/1008:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
2024/01/1008:04Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LABStandard BioTools Inc
 검색 관련기사 보기:NASDAQ:LAB